/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Johnson & Johnson Share Price Today: Live Updates & Key Insights

Johnson & Johnson share price today is $242.04, up -0.39%. The stock opened at $241.46 against the previous close of $242.99, with an intraday high of $244.4 and low of $240.34.

Johnson & Johnson Share Price Chart

style
pb-0

Johnson & Johnson

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Johnson & Johnson Share Price Performance

$242.04 -0.0039(-0.39%) JNJ at 13 Mar 2026 01:48 PM Drug Manufacturers - General
Lowest Today 240.34
Highest Today 244.4
Today’s Open 241.46
Prev. Close 242.99
52 Week High 251.71
52 Week Low 137.67
Day’s Range: Low 240.34 High 244.4
52-Week Range: Low 137.67 High 251.71
1 day return -
1 Week return +0.68
1 month return -0.53
3 month return +13.03
6 month return +36.43
1 year return +48.53
3 year return +58.2
5 year return +50.96
10 year return -

Johnson & Johnson Institutional Holdings

Vanguard Group Inc 9.97

BlackRock Inc 8.60

State Street Corp 5.49

JPMorgan Chase & Co 4.87

Vanguard Total Stock Mkt Idx Inv 3.15

Vanguard 500 Index Investor 2.55

Geode Capital Management, LLC 2.33

Morgan Stanley - Brokerage Accounts 2.00

NORGES BANK 1.39

State Farm Mutual Automobile Ins Co 1.31

iShares Core S&P 500 ETF 1.27

Fidelity 500 Index 1.27

Northern Trust Corp 1.24

State Street® SPDR® S&P 500® ETF 1.19

Bank of America Corp 1.18

Bank of New York Mellon Corp 1.02

Wellington Management Company LLP 0.96

Vanguard Value Index Inv 0.92

Charles Schwab Investment Management Inc 0.79

FMR Inc 0.78

Legal & General Group PLC 0.78

Wells Fargo & Co 0.77

State Street®HlthCrSelSectSPDR®ETF 0.74

Dimensional Fund Advisors, Inc. 0.72

Massachusetts Financial Services Company 0.68

Franklin Resources Inc 0.67

UBS Asset Mgmt Americas Inc 0.66

Vanguard Institutional Index I 0.57

Vanguard Dividend Appreciation ETF 0.55

State St S&P 500® Indx SL Cl III 0.53

Vanguard Institutional 500 Index Trust 0.45

Vanguard High Dividend Yield ETF 0.40

Blackrock Eq Idx Fund CF 0.36

Russell 1000 Index Fund 0.32

Columbia Dividend Value 0.32

Columbia Dividend Income Inst 0.32

Blackrock Russ 1000 Eq Idx Composite 0.31

Vanguard Equity-Income Inv 0.30

Vanguard Health Care ETF 0.30

MFS Large Cap Value Equity 0.29

Johnson & Johnson Market Status

Strong Buy: 7

Buy: 4

Hold: 13

Sell: 0

Strong Sell: 0

Johnson & Johnson Fundamentals

Market Cap 585581.40 M

PB Ratio 7.1812

PE Ratio 22.0299

Enterprise Value 613412.34 M

Total Assets 199210.00 M

Volume 7710152

Johnson & Johnson Company Financials

Annual Revenue FY25:94193000000 94193.0M, FY24:88821000000 88821.0M, FY23:85152000000 85152.0M, FY22:94943000000 94943.0M, FY21:93775000000 93775.0M

Annual Profit FY25:68558000000 68558.0M, FY24:61350000000 61350.0M, FY23:58413000000 58413.0M, FY22:63854000000 63854.0M, FY21:63920000000 63920.0M

Annual Net worth FY25:26804000000 26804.0M, FY24:14066000000 14066.0M, FY23:35153000000 35153.0M, FY22:17941000000 17941.0M, FY21:20878000000 20878.0M

Quarterly Revenue Q4/2025:24564000000 24564.0M, Q3/2025:23993000000 23993.0M, Q2/2025:23743000000 23743.0M, Q1/2025:21893000000 21893.0M, Q4/2024:22520000000 22520.0M

Quarterly Profit Q4/2025:21217000000 21217.0M, Q3/2025:16690000000 16690.0M, Q2/2025:16115000000 16115.0M, Q1/2025:14536000000 14536.0M, Q4/2024:15392000000 15392.0M

Quarterly Net worth Q4/2025:5116000000 5116.0M, Q3/2025:5152000000 5152.0M, Q2/2025:5537000000 5537.0M, Q1/2025:10999000000 10999.0M, Q4/2024:3431000000 3431.0M

About Johnson & Johnson & investment objective

Company Information Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Organisation Drug Manufacturers - General

Employees 138200

Industry Drug Manufacturers - General

CEO Mr. Joaquin Duato

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow